Great West Life Assurance CO Iovance Biotherapeutics, Inc. Transaction History

Great West Life Assurance CO

$58 Billion
Q4 2024

A detailed history of Great West Life Assurance CO transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 57,265 shares of IOVA stock, worth $204,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,265

Previous 60,749 5.74%

Holding current value

$204,436

Previous $571,000 25.74%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$7.17 - $12.28 $24,980 - $42,783	-3,484 Reduced 5.74%	57,265 $424,000
Q3 2024 Nov 13, 2024	BUY	$7.28 - $11.9 $5,365 - $8,770	737 Added 1.23%	60,749 $571,000
Q2 2024 Aug 12, 2024	BUY	$7.78 - $14.19 $125,522 - $228,941	16,134 Added 36.77%	60,012 $481,000
Q1 2024 May 13, 2024	BUY	$7.59 - $17.47 $157,705 - $362,991	20,778 Added 89.95%	43,878 $650,000
Q4 2023 Feb 13, 2024	SELL	$3.3 - $8.89 $3,712 - $10,001	-1,125 Reduced 4.64%	23,100 $187,000
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $36,869 - $72,992	8,304 Added 52.16%	24,225 $110,000
Q2 2023 Aug 10, 2023	BUY	$5.36 - $9.06 $40,628 - $68,674	7,580 Added 90.88%	15,921 $113,000
Q1 2023 May 12, 2023	BUY	$5.53 - $8.22 $3,710 - $5,515	671 Added 8.75%	8,341 $51,000
Q4 2022 Feb 10, 2023	BUY	$5.62 - $10.0 $1,882 - $3,350	335 Added 4.57%	7,670 $49,000
Q3 2022 Nov 01, 2022	BUY	$9.53 - $13.11 $1,591 - $2,189	167 Added 2.33%	7,335 $70,000
Q2 2022 Aug 12, 2022	BUY	$6.38 - $18.33 $45,731 - $131,389	7,168 New	7,168 $79,000
Q2 2022 Aug 09, 2022	SELL	$6.38 - $18.33 $44,736 - $128,529	-7,012 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$12.38 - $19.1 $1,993 - $3,075	161 Added 2.35%	7,012 $123,000
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $2,532 - $4,227	153 Added 2.28%	6,851 $130,000
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $13,188 - $24,191	-460 Reduced 6.43%	6,698 $211,000
Q3 2020 Nov 17, 2020	BUY	$27.75 - $36.3 $110,250 - $144,219	3,973 Added 124.74%	7,158 $235,000
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $110,250 - $144,219	-3,973 Reduced 55.5%	3,185 $104,000
Q4 2019 Feb 11, 2020	BUY	$17.95 - $29.41 $128,486 - $210,516	7,158 New	7,158 $198,000
Q3 2019 Oct 25, 2019	SELL	$17.99 - $26.0 $261,538 - $377,988	-14,538 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$7.51 - $11.93 $43,956 - $69,826	5,853 Added 67.39%	14,538 $124,000
Q1 2018 May 10, 2018	SELL	$8.1 - $19.5 $55,533 - $133,692	-6,856 Reduced 44.12%	8,685 $147,000
Q4 2017 Feb 09, 2018	BUY	$6.65 - $9.25 $103,347 - $143,754	15,541	15,541 $123,000

Others Institutions Holding IOVA

# of Institutions

343

Shares Held

247M

Call Options Held

2.51M

Put Options Held

3.5M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $563M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Iovance Biotherapeutics, Inc. Transaction History